Krishna Institute of Medical Sciences Limited – Globe Capital
Krishna Institute of Medical Sciences Limited
Closed
Price Band
Rs. 815 – 825
IPO Issue Period
Jun 16, 2021 to Jun 18, 2021
Issue Size
Rs. 2143.74 Cr.
Face value
Rs. 10/-
Fresh issue
Rs. 200 Cr.
Offer for sale
Rs. 1943.74Cr.
Minimum Shares for Retail
18 shares
Maximum Shares for Retail
234 shares
Listing on
NSE, BSE
Issue Type
Book Building
Tentative Listing Date
28-Jun-21
QIB
Not More than 75% of the offer
NII
Not less than 15% of the offer
Retail
Not less than 10% of the offer
Registrar to the Issue
Link Intime India Private Ltd

Axis Capital Limited, Credit Suisse Securities (India) Private Limited, IIFL Holdings Limited, Kotak Mahindra Capital Company Limited

Krishna Institute of Medical Sciences Limited (“KIMS”) was incorporated as Jagjit Singh and Sons Private Limited on July 26, 1973. KIMS is one of the largest corporate healthcare groups in AP and Telangana in terms of number of patients treated and treatments offered. They operate 9 multispecialty hospitals under the “KIMS Hospitals” brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021, which are 2.2 times more beds than the 2nd largest provider in AP and Telangana. KIMS offers a comprehensive range of healthcare services across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopedics, organ transplantation, renal sciences and mother & child care. Dr. Bhaskara Rao Bollineni, Rajyasri Bollineni, Dr. Abhinay Bollineni, Adwik Bollineni, and Bollineni Ramanaiah Memorial Hospitals Private Limited are the company promoters.

For year/ period ended ( in Cr.)

31 Mar 2021 31 Mar 2020 31 Mar 2019
Total Revenue 1329.94 1122.65 918.01
Profit After Tax 205.48 115.07 -48.81
EPS 26.87 15.87 -5.32
OPM(%) 28.43% 22.24% 18.83%
PATM(%) 15.45% 10.25% -5.32%
  • It is one of the largest corporate healthcare service providers in AP and Telangana.
  • It has highly qualified and trained doctors and medical support staff.
  • It has strong operational and financial performance.
  • Experienced managerial team.
  • To make repayment/prepayment of borrowings availaled by the firm and subsidiaries i.e. KHKPL, SIMSPL, and KHEPL.
  • To meet general corporate purposes.

The Company is growing at ~26% CAGR basis in last 3 years which is highest in among peers. Considering the growth prospects of healthcare sector & company’s expansion plan will beneficial for its near future. Hence, investor can subscribe to the issue for the medium to long-term.

Open Account